Table 2.
Characteristics of 8q Status of All SF3B1MUT Grouped Based on DFS in the Rotterdam Ocular Melanoma Study Group Cohort
| SF3B1MUT Tumors | DFS < 60 mos (n = 25) | DFS ≥ 60 mos (n = 34) |
|---|---|---|
| 2 copies of 8q, n (%) | 4 (16) | 7 (21) |
| 3 copies of 8q, n (%) | 16 (64) | 21 (61) |
| ≥ 4 copies of 8q, n (%) | 5 (20) | 6 (18) |
| 8q gain, n (%) | 21 (84) | 27 (79) |
DFS = disease-free survival; SF3B1MUT = splicing factor 3b subunit 1-mutated.